Barral-Netto M - Search Results

1

Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.

Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, Gollob KJ. Bottrel RL, et al. Infect Immun. 2001 May;69(5):3232-9. doi: 10.1128/IAI.69.5.3232-3239.2001. Infect Immun. 2001. PMID: 11292745 Free PMC article.

2

Tumor necrosis factor (cachectin) in human visceral leishmaniasis.

Barral-Netto M, Badaró R, Barral A, Almeida RP, Santos SB, Badaró F, Pedral-Sampaio D, Carvalho EM, Falcoff E, Falcoff R. Barral-Netto M, et al. J Infect Dis. 1991 Apr;163(4):853-7. doi: 10.1093/infdis/163.4.853. J Infect Dis. 1991. PMID: 1901333

3

Transforming growth factor-beta in human cutaneous leishmaniasis.

Barral A, Teixeira M, Reis P, Vinhas V, Costa J, Lessa H, Bittencourt AL, Reed S, Carvalho EM, Barral-Netto M. Barral A, et al. Am J Pathol. 1995 Oct;147(4):947-54. Am J Pathol. 1995. PMID: 7573370 Free PMC article.

4

Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects.

Barral A, Costa JM, Bittencourt AL, Barral-Netto M, Carvalho EM. Barral A, et al. Int J Dermatol. 1995 Jul;34(7):474-9. doi: 10.1111/j.1365-4362.1995.tb00613.x. Int J Dermatol. 1995. PMID: 7591410

5

Cytotoxicity in human mucosal and cutaneous leishmaniasis.

Barral-Netto M, Barral A, Brodskyn C, Carvalho EM, Reed SG. Barral-Netto M, et al. Parasite Immunol. 1995 Jan;17(1):21-8. doi: 10.1111/j.1365-3024.1995.tb00962.x. Parasite Immunol. 1995. PMID: 7731732

6

Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice.

Almeida RP, Barral-Netto M, De Jesus AM, De Freitas LA, Carvalho EM, Barral A. Almeida RP, et al. Am J Trop Med Hyg. 1996 Feb;54(2):178-84. doi: 10.4269/ajtmh.1996.54.178. Am J Trop Med Hyg. 1996. PMID: 8619444

7

Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.

Bomfim G, Nascimento C, Costa J, Carvalho EM, Barral-Netto M, Barral A. Bomfim G, et al. Exp Parasitol. 1996 Nov;84(2):188-94. doi: 10.1006/expr.1996.0104. Exp Parasitol. 1996. PMID: 8932768

8

Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers.

Pompeu MM, Brodskyn C, Teixeira MJ, Clarêncio J, Van Weyenberg J, Coelho IC, Cardoso SA, Barral A, Barral-Netto M. Pompeu MM, et al. Infect Immun. 2001 Dec;69(12):7453-60. doi: 10.1128/IAI.69.12.7453-7460.2001. Infect Immun. 2001. PMID: 11705920 Free PMC article.

9

Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.

Carvalho EM, Barral A, Pedral-Sampaio D, Barral-Netto M, Badaró R, Rocha H, Johnson WD Jr. Carvalho EM, et al. J Infect Dis. 1992 Mar;165(3):535-40. doi: 10.1093/infdis/165.3.535. J Infect Dis. 1992. PMID: 1347057

10

Diffuse cutaneous leishmaniasis with atypical aspects.

Bittencourt AL, Barral A, Costa JM, Saldanha AC, Badaró F, Barral-Netto M, Freitas LA. Bittencourt AL, et al. Int J Dermatol. 1992 Aug;31(8):568-70. doi: 10.1111/j.1365-4362.1992.tb02721.x. Int J Dermatol. 1992. PMID: 1428449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters